Haemonetics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Haemonetics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 12% to $1,309,055,000. The net income raised on $117,558,000 and profit margin reached 9%. Total operating expenses were $526,665,000.
Profit Margin
| 2015 | 910.37M | 16.89M | 1.86% |
|---|---|---|---|
| 2016 | 909.67M | -55.62M | -6.11% |
| 2017 | 886.11M | -26.26M | -2.96% |
| 2018 | 903.92M | 45.57M | 5.04% |
| 2019 | 967.57M | 55.01M | 5.69% |
| 2020 | 988.47M | 76.52M | 7.74% |
| 2021 | 870.46M | 79.46M | 9.13% |
| 2022 | 993.19M | 43.37M | 4.37% |
| 2023 | 1.16B | 115.40M | 9.87% |
| 2024 | 1.30B | 117.55M | 8.98% |
HAE Income Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.30B | 1.16B | 993.19M | 870.46M | 988.47M | 967.57M | 903.92M | 886.11M | 909.67M | 910.37M |
Cost of revenue | 617.50M | 553.56M | 487.69M | 472.62M | 503.96M | 550.04M | 492.01M | 507.62M | 503.80M | 475.95M |
Gross profit | 691.54M | 615.09M | 505.50M | 397.83M | 484.51M | 417.53M | 411.90M | 378.49M | 405.87M | 434.41M |
Operating exp. | ||||||||||
Research and development | 54.43M | 50.13M | 46.80M | 32.85M | 30.88M | 35.71M | 39.22M | 37.55M | 45.56M | 54.18M |
Selling and marketing | 7.1M | 7.2M | 4.4M | 2.7M | 4.3M | 4.5M | 3.1M | 2.5M | 3.9M | 4.5M |
Total operating expenses | 526.66M | 459.06M | 433.77M | 339.87M | 330.56M | 333.99M | 355.75M | 339.28M | 369.53M | 393.87M |
Operating income | 164.88M | 156.03M | 80.75M | 57.96M | 153.95M | 83.54M | 56.15M | -19.38M | -43.98M | 40.54M |
Other income (expenses), net | -13.01M | -14.63M | -17.12M | 14.95M | -16.19M | -9.91M | 8M | -8.09M | -80.32M | -9.37M |
Income before tax | 151.86M | 141.40M | 63.62M | 72.91M | 87.15M | 73.63M | 59.63M | -27.47M | -53.45M | 31.16M |
Income tax expense | 34.30M | 26.00M | 20.25M | -6.55M | 10.62M | 18.61M | 14.06M | -1.20M | 2.16M | 14.26M |
Net income | 117.55M | 115.40M | 43.37M | 79.46M | 76.52M | 55.01M | 45.57M | -26.26M | -55.62M | 16.89M |
Earnings per share | ||||||||||
Basic EPS | 2.32 | 2.27 | 0.85 | 1.57 | 1.51 | 1.07 | 0.86 | -0.51 | -1.09 | 0.33 |
Diluted EPS | 2.29 | 2.24 | 0.84 | 1.55 | 1.48 | 1.04 | 0.85 | -0.51 | -1.09 | 0.32 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |